Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-16-124834

Options or other derivatives

  • Director acquired 6,231 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Saad Mark E Director 2016-05-27 Grant or award · Stock Option (Right to Buy) +6,231 6,231 D
Loading xslF345X03/a4.xml…